elranatamab will raise the amount or impact of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Elranatamab causes cytokine release syndrome (CRS) that could suppress activity of CYP enzymes, resulting in increased publicity of CYP substrates.butorphanol decreases outcomes of fentanyl transdermal b